Chinese drugmaker Guangzhou Innogen Pharmaceutical had a strong debut in Hong Kong, cashing in on positive sentiment toward its flagship drug and Chinese biotech stocks in general.

Huge dividends from Denmark’s weight loss drug industry are result of high-tax and high-investment economy, says Nobel Prize winner Morten Meldal.

Eli Lilly is to raise the UK list price of its weight-loss and type 2 diabetes treatment Mounjaro by up to 170pc to be in line with other European markets, it has said, as the pharma industry responds ...

At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...

Modi reinforced his previous recommendations to address the crisis, urging families to purchase 10% less cooking oil, and ...

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa, marking its debut in Africa and ...

The new price, which also applies to Lilly's type 2 diabetes medicine that has the same name, is effective from September ...

The manufacturers of a new weight-loss drug recently rolled out by the NHS are upping their prices by 170%. Eli Lilly is ...

Eli Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro for people who buy the drug ...

Broadcom rides AI growth and VMware integration, Philip Morris pushes smoke-free transition, while Novo Nordisk grapples with ...

Researchers uncover ‘dangerous’ threat of global scam operation affecting millions as health regulators warn fraudulent ...

More than 1 in 4 adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, the ...